Respiratory Disease Efficacy Evaluation
Respiratory disease encompasses a wide range of pathological conditions affecting the organs and tissues involved in gas exchange in the body. These conditions represent a significant global health burden, causing substantial morbidity and mortality worldwide. From acute infections to chronic inflammatory disorders, respiratory diseases vary widely in their presentation, progression, and treatment approaches. Various models have been developed to study common respiratory ailments such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis, contributing significantly to our understanding of disease mechanisms and identification of potential therapeutic targets.
-
Acute Lung Injury (ALI) Models
Acute lung injury is a serious respiratory condition characterized by acute pulmonary inflammation with disruption of the pulmonary vasculature endothelial and alveolar epithelial barriers. It can occur from various causes including pulmonary infections, trauma, sepsis, and certain drugs, resulting in hypoxemia and diffuse pulmonary infiltrates visible on chest imaging, and often referred to by its most severe subset known as acute respiratory distress syndrome (ARDS).
-
Idiopathic Pulmonary Fibrosis (IPF) Models
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing lung disease characterized by worsening lung scarring and a usual interstitial pneumonia pattern. It is a rapidly progressive illness of unknown cause with subsequent scarring that leads to end-stage lung disease.
-
Chronic Obstructive Pulmonary Disease (COPD) Models
Chronic Obstructive Pulmonary Disease (COPD) is a major public health concern with global scope that remains a significant cause of morbidity and mortality worldwide. It is a progressive respiratory illness characterized by persistent respiratory symptoms and airflow limitation, currently ranked as the sixth leading cause of mortality in the United States.
-
Bronchiectasis Models
Bronchiectasis is a chronic respiratory condition characterized by permanent dilation of bronchi, resulting in cough, sputum production, and recurrent chest infections.
-
Pulmonary Function Test
Pulmonary function testing in mice provides essential data for understanding respiratory physiology and pathophysiology in preclinical research. These tests enable researchers to quantify lung mechanics, evaluate disease progression, and assess therapeutic interventions in mouse models of various respiratory conditions.